Results 171 to 180 of about 466,026 (339)
Approximate Analytical Solution of Index-2 DAEs Arising from Constrained Multibody Systems
Brahim Benhammouda
openalex +1 more source
Approximate analytic solution for multi-dimensional fractional wave-like equation
Jian-She Sun
openalex +2 more sources
Approximate analytical solution to the Boussinesq equation with a sloping water‐land boundary [PDF]
Yuehao Tang +2 more
openalex +1 more source
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon +9 more
wiley +1 more source
Hybrid expansion methods for fractional non-linear mathematical systems with Erdelyi-Kober derivative operators in theory of tsunami wave modeling. [PDF]
Damag FH +5 more
europepmc +1 more source
Approximate Analytic solution of higher order nonlinear system of ODEs by Shooting Type Laplace Adomian Decomposition Algorithm [PDF]
Baiju S
openalex +1 more source
Etoposide induces DNA damage, activating p53‐dependent apoptosis via caspase‐3/7, which cleaves PARP1. Dammarenediol II enhances this apoptotic pathway by suppressing O‐GlcNAc transferase activity, further decreasing O‐GlcNAcylation. The reduction in O‐GlcNAc levels boosts p53‐driven apoptosis and influences the Akt/GSK3β/mTOR signaling pathway ...
Jaehoon Lee +8 more
wiley +1 more source
Fractional modeling of nonlinear dispersive systems: on the comparative study of Whitham-Broer-Kaup equations using various derivatives. [PDF]
Ahmed SA +6 more
europepmc +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source

